- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Imbruvica market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Imbruvica market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Mantle Cell Lymphoma accounting for % of the Imbruvica global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 5 mg segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Imbruvica include AbbVie (Pharmacyclics), Johnson & Johnson (Janssen Biotech), SP Laboratories, , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Imbruvica market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
5 mg
10 mg
140 mg
Market segment by Application, can be divided into
Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia
Waldenström's Macroglobulinemia
Relapsed/Refractory Marginal Zone Lymphoma
Chronic Graft-Versus-Host-Disease
Market segment by players, this report covers
AbbVie (Pharmacyclics)
Johnson & Johnson (Janssen Biotech)
SP Laboratories
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Imbruvica product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Imbruvica, with revenue, gross margin and global market share of Imbruvica from 2019 to 2022.
Chapter 3, the Imbruvica competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Imbruvica market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Imbruvica research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Imbruvica
1.2 Classification of Imbruvica by Type
1.2.1 Overview: Global Imbruvica Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Imbruvica Revenue Market Share by Type in 2021
1.2.3 5 mg
1.2.4 10 mg
1.2.5 140 mg
1.3 Global Imbruvica Market by Application
1.3.1 Overview: Global Imbruvica Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Mantle Cell Lymphoma
1.3.3 Chronic Lymphocytic Leukemia
1.3.4 Waldenström's Macroglobulinemia
1.3.5 Relapsed/Refractory Marginal Zone Lymphoma
1.3.6 Chronic Graft-Versus-Host-Disease
1.4 Global Imbruvica Market Size & Forecast
1.5 Global Imbruvica Market Size and Forecast by Region
1.5.1 Global Imbruvica Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Imbruvica Market Size by Region, (2017-2022)
1.5.3 North America Imbruvica Market Size and Prospect (2017-2028)
1.5.4 Europe Imbruvica Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Imbruvica Market Size and Prospect (2017-2028)
1.5.6 South America Imbruvica Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Imbruvica Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Imbruvica Market Drivers
1.6.2 Imbruvica Market Restraints
1.6.3 Imbruvica Trends Analysis
2 Company Profiles
2.1 AbbVie (Pharmacyclics)
2.1.1 AbbVie (Pharmacyclics) Details
2.1.2 AbbVie (Pharmacyclics) Major Business
2.1.3 AbbVie (Pharmacyclics) Imbruvica Product and Solutions
2.1.4 AbbVie (Pharmacyclics) Imbruvica Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 AbbVie (Pharmacyclics) Recent Developments and Future Plans
2.2 Johnson & Johnson (Janssen Biotech)
2.2.1 Johnson & Johnson (Janssen Biotech) Details
2.2.2 Johnson & Johnson (Janssen Biotech) Major Business
2.2.3 Johnson & Johnson (Janssen Biotech) Imbruvica Product and Solutions
2.2.4 Johnson & Johnson (Janssen Biotech) Imbruvica Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Johnson & Johnson (Janssen Biotech) Recent Developments and Future Plans
2.3 SP Laboratories
2.3.1 SP Laboratories Details
2.3.2 SP Laboratories Major Business
2.3.3 SP Laboratories Imbruvica Product and Solutions
2.3.4 SP Laboratories Imbruvica Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 SP Laboratories Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Imbruvica Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Imbruvica Players Market Share in 2021
3.2.2 Top 10 Imbruvica Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Imbruvica Players Head Office, Products and Services Provided
3.4 Imbruvica Mergers & Acquisitions
3.5 Imbruvica New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Imbruvica Revenue and Market Share by Type (2017-2022)
4.2 Global Imbruvica Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Imbruvica Revenue Market Share by Application (2017-2022)
5.2 Global Imbruvica Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Imbruvica Revenue by Type (2017-2028)
6.2 North America Imbruvica Revenue by Application (2017-2028)
6.3 North America Imbruvica Market Size by Country
6.3.1 North America Imbruvica Revenue by Country (2017-2028)
6.3.2 United States Imbruvica Market Size and Forecast (2017-2028)
6.3.3 Canada Imbruvica Market Size and Forecast (2017-2028)
6.3.4 Mexico Imbruvica Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Imbruvica Revenue by Type (2017-2028)
7.2 Europe Imbruvica Revenue by Application (2017-2028)
7.3 Europe Imbruvica Market Size by Country
7.3.1 Europe Imbruvica Revenue by Country (2017-2028)
7.3.2 Germany Imbruvica Market Size and Forecast (2017-2028)
7.3.3 France Imbruvica Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Imbruvica Market Size and Forecast (2017-2028)
7.3.5 Russia Imbruvica Market Size and Forecast (2017-2028)
7.3.6 Italy Imbruvica Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Imbruvica Revenue by Type (2017-2028)
8.2 Asia-Pacific Imbruvica Revenue by Application (2017-2028)
8.3 Asia-Pacific Imbruvica Market Size by Region
8.3.1 Asia-Pacific Imbruvica Revenue by Region (2017-2028)
8.3.2 China Imbruvica Market Size and Forecast (2017-2028)
8.3.3 Japan Imbruvica Market Size and Forecast (2017-2028)
8.3.4 South Korea Imbruvica Market Size and Forecast (2017-2028)
8.3.5 India Imbruvica Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Imbruvica Market Size and Forecast (2017-2028)
8.3.7 Australia Imbruvica Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Imbruvica Revenue by Type (2017-2028)
9.2 South America Imbruvica Revenue by Application (2017-2028)
9.3 South America Imbruvica Market Size by Country
9.3.1 South America Imbruvica Revenue by Country (2017-2028)
9.3.2 Brazil Imbruvica Market Size and Forecast (2017-2028)
9.3.3 Argentina Imbruvica Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Imbruvica Revenue by Type (2017-2028)
10.2 Middle East & Africa Imbruvica Revenue by Application (2017-2028)
10.3 Middle East & Africa Imbruvica Market Size by Country
10.3.1 Middle East & Africa Imbruvica Revenue by Country (2017-2028)
10.3.2 Turkey Imbruvica Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Imbruvica Market Size and Forecast (2017-2028)
10.3.4 UAE Imbruvica Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Imbruvica Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Imbruvica Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Imbruvica Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Imbruvica Revenue (USD Million) by Region (2017-2022)
Table 5. Global Imbruvica Revenue Market Share by Region (2023-2028)
Table 6. AbbVie (Pharmacyclics) Corporate Information, Head Office, and Major Competitors
Table 7. AbbVie (Pharmacyclics) Major Business
Table 8. AbbVie (Pharmacyclics) Imbruvica Product and Solutions
Table 9. AbbVie (Pharmacyclics) Imbruvica Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Johnson & Johnson (Janssen Biotech) Corporate Information, Head Office, and Major Competitors
Table 11. Johnson & Johnson (Janssen Biotech) Major Business
Table 12. Johnson & Johnson (Janssen Biotech) Imbruvica Product and Solutions
Table 13. Johnson & Johnson (Janssen Biotech) Imbruvica Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. SP Laboratories Corporate Information, Head Office, and Major Competitors
Table 15. SP Laboratories Major Business
Table 16. SP Laboratories Imbruvica Product and Solutions
Table 17. SP Laboratories Imbruvica Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Global Imbruvica Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 19. Global Imbruvica Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 20. Breakdown of Imbruvica by Company Type (Tier 1, Tier 2 and Tier 3)
Table 21. Imbruvica Players Head Office, Products and Services Provided
Table 22. Imbruvica Mergers & Acquisitions in the Past Five Years
Table 23. Imbruvica New Entrants and Expansion Plans
Table 24. Global Imbruvica Revenue (USD Million) by Type (2017-2022)
Table 25. Global Imbruvica Revenue Share by Type (2017-2022)
Table 26. Global Imbruvica Revenue Forecast by Type (2023-2028)
Table 27. Global Imbruvica Revenue by Application (2017-2022)
Table 28. Global Imbruvica Revenue Forecast by Application (2023-2028)
Table 29. North America Imbruvica Revenue by Type (2017-2022) & (USD Million)
Table 30. North America Imbruvica Revenue by Type (2023-2028) & (USD Million)
Table 31. North America Imbruvica Revenue by Application (2017-2022) & (USD Million)
Table 32. North America Imbruvica Revenue by Application (2023-2028) & (USD Million)
Table 33. North America Imbruvica Revenue by Country (2017-2022) & (USD Million)
Table 34. North America Imbruvica Revenue by Country (2023-2028) & (USD Million)
Table 35. Europe Imbruvica Revenue by Type (2017-2022) & (USD Million)
Table 36. Europe Imbruvica Revenue by Type (2023-2028) & (USD Million)
Table 37. Europe Imbruvica Revenue by Application (2017-2022) & (USD Million)
Table 38. Europe Imbruvica Revenue by Application (2023-2028) & (USD Million)
Table 39. Europe Imbruvica Revenue by Country (2017-2022) & (USD Million)
Table 40. Europe Imbruvica Revenue by Country (2023-2028) & (USD Million)
Table 41. Asia-Pacific Imbruvica Revenue by Type (2017-2022) & (USD Million)
Table 42. Asia-Pacific Imbruvica Revenue by Type (2023-2028) & (USD Million)
Table 43. Asia-Pacific Imbruvica Revenue by Application (2017-2022) & (USD Million)
Table 44. Asia-Pacific Imbruvica Revenue by Application (2023-2028) & (USD Million)
Table 45. Asia-Pacific Imbruvica Revenue by Region (2017-2022) & (USD Million)
Table 46. Asia-Pacific Imbruvica Revenue by Region (2023-2028) & (USD Million)
Table 47. South America Imbruvica Revenue by Type (2017-2022) & (USD Million)
Table 48. South America Imbruvica Revenue by Type (2023-2028) & (USD Million)
Table 49. South America Imbruvica Revenue by Application (2017-2022) & (USD Million)
Table 50. South America Imbruvica Revenue by Application (2023-2028) & (USD Million)
Table 51. South America Imbruvica Revenue by Country (2017-2022) & (USD Million)
Table 52. South America Imbruvica Revenue by Country (2023-2028) & (USD Million)
Table 53. Middle East & Africa Imbruvica Revenue by Type (2017-2022) & (USD Million)
Table 54. Middle East & Africa Imbruvica Revenue by Type (2023-2028) & (USD Million)
Table 55. Middle East & Africa Imbruvica Revenue by Application (2017-2022) & (USD Million)
Table 56. Middle East & Africa Imbruvica Revenue by Application (2023-2028) & (USD Million)
Table 57. Middle East & Africa Imbruvica Revenue by Country (2017-2022) & (USD Million)
Table 58. Middle East & Africa Imbruvica Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Imbruvica Picture
Figure 2. Global Imbruvica Revenue Market Share by Type in 2021
Figure 3. 5 mg
Figure 4. 10 mg
Figure 5. 140 mg
Figure 6. Imbruvica Revenue Market Share by Application in 2021
Figure 7. Mantle Cell Lymphoma Picture
Figure 8. Chronic Lymphocytic Leukemia Picture
Figure 9. Waldenström's Macroglobulinemia Picture
Figure 10. Relapsed/Refractory Marginal Zone Lymphoma Picture
Figure 11. Chronic Graft-Versus-Host-Disease Picture
Figure 12. Global Imbruvica Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Imbruvica Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Imbruvica Revenue Market Share by Region (2017-2028)
Figure 15. Global Imbruvica Revenue Market Share by Region in 2021
Figure 16. North America Imbruvica Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Imbruvica Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Imbruvica Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Imbruvica Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Imbruvica Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Imbruvica Market Drivers
Figure 22. Imbruvica Market Restraints
Figure 23. Imbruvica Market Trends
Figure 24. AbbVie (Pharmacyclics) Recent Developments and Future Plans
Figure 25. Johnson & Johnson (Janssen Biotech) Recent Developments and Future Plans
Figure 26. SP Laboratories Recent Developments and Future Plans
Figure 27. Global Imbruvica Revenue Share by Players in 2021
Figure 28. Imbruvica Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 29. Global Top 3 Players Imbruvica Revenue Market Share in 2021
Figure 30. Global Top 10 Players Imbruvica Revenue Market Share in 2021
Figure 31. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 32. Global Imbruvica Revenue Share by Type in 2021
Figure 33. Global Imbruvica Market Share Forecast by Type (2023-2028)
Figure 34. Global Imbruvica Revenue Share by Application in 2021
Figure 35. Global Imbruvica Market Share Forecast by Application (2023-2028)
Figure 36. North America Imbruvica Sales Market Share by Type (2017-2028)
Figure 37. North America Imbruvica Sales Market Share by Application (2017-2028)
Figure 38. North America Imbruvica Revenue Market Share by Country (2017-2028)
Figure 39. United States Imbruvica Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Imbruvica Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Imbruvica Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Imbruvica Sales Market Share by Type (2017-2028)
Figure 43. Europe Imbruvica Sales Market Share by Application (2017-2028)
Figure 44. Europe Imbruvica Revenue Market Share by Country (2017-2028)
Figure 45. Germany Imbruvica Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. France Imbruvica Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. United Kingdom Imbruvica Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Russia Imbruvica Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Italy Imbruvica Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Asia-Pacific Imbruvica Sales Market Share by Type (2017-2028)
Figure 51. Asia-Pacific Imbruvica Sales Market Share by Application (2017-2028)
Figure 52. Asia-Pacific Imbruvica Revenue Market Share by Region (2017-2028)
Figure 53. China Imbruvica Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Japan Imbruvica Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. South Korea Imbruvica Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. India Imbruvica Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Southeast Asia Imbruvica Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Australia Imbruvica Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. South America Imbruvica Sales Market Share by Type (2017-2028)
Figure 60. South America Imbruvica Sales Market Share by Application (2017-2028)
Figure 61. South America Imbruvica Revenue Market Share by Country (2017-2028)
Figure 62. Brazil Imbruvica Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Argentina Imbruvica Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Middle East and Africa Imbruvica Sales Market Share by Type (2017-2028)
Figure 65. Middle East and Africa Imbruvica Sales Market Share by Application (2017-2028)
Figure 66. Middle East and Africa Imbruvica Revenue Market Share by Country (2017-2028)
Figure 67. Turkey Imbruvica Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Saudi Arabia Imbruvica Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. UAE Imbruvica Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Methodology
Figure 71. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
